CardioGenesis Corporation

Global leader in TMR and PMR (International markets only)

An innovative and leading angiogenesis device company providing products that stimulate cardiac angiogenesis

Developer of innovative technologies and therapies

Unparalleled commitment to delivering life-changing therapies for the patient

Provider of the highest quality and most reliable devices in our industry

Our effective new treatments provide cardiac patients the opportunity to have the rich full life they deserve

Contact Details: 26632 Towne Centre DriveSuite 320 Foothill Ranch CA 92610 United States of America Tel: (714) 649-5000 Fax: Email: cocampo@cardiogenesis.com WWW: www.eclipsesurg.com/

Loading...

Recent Publications by CardioGenesis Corporation:
Interplay of Oct4 with Sox2 and Sox17: a molecular switch from stem cell pluripotency to specifying a cardiac fate. Oct4 exerts a dose-dependent dual action, as both a gatekeeper for stem...	9th September, 2009	Institut National de la Sante et de la Recherche Medicale (INSERM), Avenir	J Cell Biol. 2009 Sep 7;186(5):665-73. DOI Direct Link

BioNews Results for CardioGenesis Corporation:
Cardiogenesis Corporation to Report Third Quarter 2009 Results on November 10th	SmartBrief:  Oct 29 2009 10:47PM Matching: cardiogenesis
Cardiogenesis Corporation to Report Third Quarter 2009 Results on November 10th	Individual.com:  Oct 29 2009 11:57AM Matching: cardiogenesis
BIOLASE Names Gregory D. Waller to Board of Directors	Freshnews.com:  Oct 26 2009 11:45AM Matching: cardiogenesis
BIOLASE Names Gregory D. Waller to Board of Directors	Genetic Engineering News:  Oct 26 2009 10:38AM Matching: cardiogenesis
BIOLASE Names Gregory D. Waller to Board of Directors	Genetic Engineering News:  Oct 26 2009 10:24AM Matching: cardiogenesis
Promote your company here: BioNewsCast - Press Release Distribution	→View more CardioGenesis Corporation news.

CardioGenesis Corporation Patents:
US Patent No.	Title
6524298	Therapeutic and diagnostic agent delivery
5554152	Method for intra-operative myocardial revascularization
5728091	Optical fiber for myocardial channel formation
5840059	Therapeutic and diagnostic agent delivery
5925033	Method for intra-operative myocardial revascularization
→View more CardioGenesis Corporation patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 439 times since April 2007, the link to the organisation's website has been followed 99 times

Recent Search Terms used to find this page: cardiogenesis patent | CardioGenesis patent | CardioGenesis patent | Cardiogenesis email | .

Search for more companies in Foothill Ranch

Search for more companies in CA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for CardioGenesis Corporation